Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation

Bone Marrow Transplantation, Published online: 13 February 2024; doi:10.1038/s41409-024-02232-3Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation

Source: Bone Marrow Transplantation - February 13, 2024 Category: Hematology Authors: Giovanna Melica Elaina Preston Meighan Palazzo Kenneth Seier Florent Malard Christina Cho Sean M. Devlin Molly Maloy Taylor Borrill Peter Maslak Gunjan L. Shah Miguel-Angel Perales Source Type: research